• search hit 35 of 1220
Back to Result List

Challenges in the drug release testing of next-generation nanomedicines – What do we know?

  • Despite all advances in drug delivery, the limitations of the analytical technologies involved in the characterization of next-generation nanomedicines are still impeding further progress of an emerging market. Discriminating between different formulations and batches, drug release is one of the most important quality criteria in development and quality control of pharmaceutics. Unfortunately, there are only few methods available to sensitively measure this important parameter for nanosized carriers. With the development of the dispersion releaser (DR) technology our group has set up a dialysis-based technique that was tested with a number of nanocarrier and nanocrystal formulations such as liposomes and polymeric nanoparticles. By supporting formulation development with a more reliable methodology to assess the drug release from nanosized carriers, a first step has been made to improve future products.

Download full text files

Export metadata

Metadaten
Author:Matthias WackerORCiDGND
URN:urn:nbn:de:hebis:30:3-773539
DOI:https://doi.org/10.1016/j.matpr.2017.09.189
ISSN:2214-7853
Parent Title (English):Materials Today: Proceedings
Publisher:Elsevier
Place of publication:Amsterdam
Document Type:Article
Language:English
Date of Publication (online):2017/11/25
Date of first Publication:2017/11/25
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:NRW Nano-Conference (7. : 2016 : Münster, Westfalen)
Release Date:2023/10/12
Tag:Dissolution nanoparticles; Liposomes; Nanocarriers; QbD; Release testing
Volume:4
Issue:Supplement 2
Page Number:4
First Page:S214
Last Page:S217
HeBIS-PPN:51657101X
Institutes:Biochemie, Chemie und Pharmazie
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung-Nicht kommerziell-Keine Bearbeitung 3.0